Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel BET bromodomain inhibitor from Epigenetix a potential clinical candidate

Dec. 30, 2015

Novel reversible bromodomain inhibitor shows promise for AML

Dec. 30, 2015

ADCT-402 shows antitumor activity against CD19-expressing B-cell malignancies

Dec. 30, 2015

Novel preclinical model for cancer cachexia

Dec. 30, 2015

Sacituzumab govitecan has antitumor activity in patients with triple-negative breast cancer

Dec. 29, 2015

New DAAO inhibitor shows promise for CNS disorders

Dec. 29, 2015

Target inhibition seen with EPZ-5676 in pediatric patients with MLL-r acute leukemia

Dec. 29, 2015

NI-0501 shows promise in pilot study in hemophagocytic lymphohistiocytosis

Dec. 29, 2015

New intermittent schedule of CC-122 mitigates neutropenia in DLBCL patients

Dec. 29, 2015

S-Oxprenolol improves survival in a preclinical model of ALS

Dec. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...